Physical activity in incident patients with pulmonary arterial and chronic thromboembolic hypertension.


Journal

Lung
ISSN: 1432-1750
Titre abrégé: Lung
Pays: United States
ID NLM: 7701875

Informations de publication

Date de publication:
10 2019
Historique:
received: 01 04 2019
accepted: 24 06 2019
pubmed: 3 7 2019
medline: 1 5 2020
entrez: 3 7 2019
Statut: ppublish

Résumé

The cardinal symptom of pulmonary hypertension (PH) is dyspnea on exertion, leading to decreased activity in daily living. The aim of this study was to analyze daily physical activity in incident patients with arterial or chronic thromboembolic PH (PAH/CTEPH) and to investigate its correlation with pulmonary hemodynamics, symptoms, exercise capacity, and other outcomes. Incident patients with PAH/CTEPH had a 1-week activity assessment by the arm-worn accelerometer SenseWear within - 3 months/+ 2 weeks of the diagnostic right heart catheterization (RHC) and baseline assessments including 6-minute walking distance (6MWD). Activity was correlated to RHC data at rest and exercise and to other outcomes. Thirty-nine PH-patients (24 PAH, 15 CTEPH, 23 females, 65(54;73) years, mean pulmonary artery pressure (mPAP) 38(30;46) mmHg, cardiac output (CO) 5.2(4.6;6.3) l/min, 6MWD 458(300;593) m) were included. 64% had a sedentary lifestyle ( < 5000 steps/day), 26% were moderately active (5000-9999 steps/day), and 10% were active. In a multivariate stepwise regression analysis including age, gender, 6MWD and hemodynamics at rest and during exercise (heart rate, mPAP, stroke volume), the 6MWD was the only independent predictor of steps/day (B = 16.8 (95% CI 11.6-22.0), p < 0.001). Daily physical activity as steps/day assessed in incident patients with PAH/CTEPH did not well correlate with invasive hemodynamics at rest or during exercise, but very well with the 6MWD. Whether daily activity assessments provide additional information to simple walk distance on risk factor profiles during follow-up in patients with PAH/CTEPH remains to be clarified.

Identifiants

pubmed: 31263960
doi: 10.1007/s00408-019-00248-x
pii: 10.1007/s00408-019-00248-x
doi:

Banques de données

ClinicalTrials.gov
['NCT02249806']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

617-625

Références

PLoS One. 2011;6(11):e27993
pubmed: 22110770
Respiration. 2018;95(1):18-26
pubmed: 29131111
Eur Respir J. 2019 Jan 24;53(1):null
pubmed: 30545969
Chest. 2016 Jul;150(1):46-56
pubmed: 26892602
Clin Respir J. 2018 Feb;12(2):699-705
pubmed: 27860259
PLoS One. 2012;7(6):e39198
pubmed: 22745715
Chest. 2016 Jul;150(1):57-67
pubmed: 26892603
Eur Heart J. 2016 Jan 1;37(1):67-119
pubmed: 26320113
Eur J Appl Physiol. 2012 May;112(5):1653-62
pubmed: 21874552
Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7
pubmed: 12091180
Am J Respir Crit Care Med. 2014 Aug 1;190(3):252-7
pubmed: 24869464
Clin Rehabil. 2007 Feb;21(2):151-62
pubmed: 17264109
Sports Med. 2004;34(1):1-8
pubmed: 14715035
Eur Respir J. 2016 Dec;48(6):1658-1667
pubmed: 27824602
Int J Behav Nutr Phys Act. 2012 Jul 09;9:84
pubmed: 22776399
Eur Respir J. 2013 Dec;42(6):1586-94
pubmed: 23794468
Eur Heart J. 2010 Aug;31(16):1967-74
pubmed: 20643803
Clin Respir J. 2018 Jan;12(1):119-125
pubmed: 27149246
Public Health Rep. 1985 Mar-Apr;100(2):126-31
pubmed: 3920711
Arch Phys Med Rehabil. 2015 Nov;96(11):2079-88.e10
pubmed: 26049088
Int J Behav Nutr Phys Act. 2011 Jul 28;8:80
pubmed: 21798044
Respir Med. 2013 May;107(5):778-84
pubmed: 23478192
Eur Respir J. 2019 Jan 24;53(1):null
pubmed: 30545968
J Cardiovasc Nurs. 2014 May-Jun;29(3):218-26
pubmed: 23416939
Respiration. 2013;86(1):45-51
pubmed: 23234873

Auteurs

Stéphanie Saxer (S)

Department of Pulmonology, University Hospital Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.
Department of Health Sciences & Health Policy, University of Lucerne, Lucerne, Switzerland.

Mona Lichtblau (M)

Department of Pulmonology, University Hospital Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.

Charlotte Berlier (C)

Department of Pulmonology, University Hospital Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.

Elisabeth D Hasler (ED)

Department of Pulmonology, University Hospital Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.

Esther I Schwarz (EI)

Department of Pulmonology, University Hospital Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.

Silvia Ulrich (S)

Department of Pulmonology, University Hospital Zurich, Rämistrasse 100, 8091, Zurich, Switzerland. silvia.ulrich@usz.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH